Literature DB >> 3606543

Effect of the blood supply to the normal noninfarcted myocardium on the incidence and severity of early post-occlusion arrhythmias in dogs.

A Végh, L Szekeres, E Udvary.   

Abstract

This work was initiated by the discrepancy existing between the traditional experimental infarction model with occlusion of one single major coronary artery in the otherwise healthy myocardium and the clinical situation in which two or more major coronary arteries are stenosed at the same time. A model mimicking this latter clinical situation was elaborated as follows: In anaesthetized, open-chest dogs the haemodynamic, electrophysiological and blood flow changes due to 5 min occlusion of the left anterior descending coronary artery (LAD) were studied in the absence and presence of a critical constriction of the left circumflex coronary artery (LCX). Control LAD occlusion resulted in enhanced ST-segment elevation and inhomogeneity of electrical activation, depressed left ventricular contractility (LVdP/dt) and local myocardial contractility, as well as in a decline of myocardial blood flow (MBF) in the ischaemic area supplied by LAD. These changes were accompanied by no or slight extrasystolic activity. In the presence of critical stenosis of LCX, occlusion of the LAD aggravated myocardial ischaemia, i.e. ST-segment elevation and diminution of MBF were more marked, mainly in the subepicardium of the ischaemic area. The incidence and severity of arrhythmias significantly increased. Even ventricular fibrillation occurred in one third of the animals, both during LAD occlusion and after its release. Thus, acute LAD occlusion in the presence of a stenosed LCX produced a more severe myocardial ischaemia associated with more severe arrhythmias than occlusion of LAD alone. This model is more relevant to the clinical situation in which multivessel coronary artery disease is common.

Entities:  

Mesh:

Year:  1987        PMID: 3606543     DOI: 10.1007/bf01907063

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  15 in total

1.  The pathophysiology of malignant ventricular arrhythmias during acute myocardial ischemia.

Authors:  D O Williams; B J Scherlag; R R Hope; N el-Sherif; R Lazzara
Journal:  Circulation       Date:  1974-12       Impact factor: 29.690

2.  Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia.

Authors:  L C Becker
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

3.  Effects of coronary stenoses on coronary flow reserve and resistance.

Authors:  K L Gould; K Lipscomb
Journal:  Am J Cardiol       Date:  1974-07       Impact factor: 2.778

4.  Effects of acute left anterior descending occlusion on regional myocardial blood flow and wall thickening in the presence of a circumflex stenosis in dogs.

Authors:  J A Gascho; E J Lesnefsky; M S Mahanes; D L Kaiser; G A Beller
Journal:  Am J Cardiol       Date:  1984-08-01       Impact factor: 2.778

5.  Effect of adrenergic activation on collateral coronary blood flow.

Authors:  A Juhász-Nagy; M Szentiványi; G Grósz
Journal:  Jpn Heart J       Date:  1974-05

6.  Importance of myocardial blood flow changes in the protective action of diltiazem in a new model of myocardial ischaemia.

Authors:  L Szekeres; E Udvary; A Végh
Journal:  Br J Pharmacol       Date:  1985-10       Impact factor: 8.739

7.  Nitroglycerin and dipyridamole on cardiac metabolism and dynamics in a new experimental model of angina pectoris.

Authors:  L Szekeres; V Csik; E Udvary
Journal:  J Pharmacol Exp Ther       Date:  1976-01       Impact factor: 4.030

8.  Effect of dilation of the distal coronary bed on flow and resistance in severely stenotic coronary arteries in the dog.

Authors:  J S Schwartz; P F Carlyle; J N Cohn
Journal:  Am J Cardiol       Date:  1979-02       Impact factor: 2.778

9.  Effect of coronary occlusion site on ischaemic bed size and collateral blood flow in dogs.

Authors:  K A Reimer; R E Ideker; R B Jennings
Journal:  Cardiovasc Res       Date:  1981-11       Impact factor: 10.787

10.  Regional redistribution of myocardial blood flow after coronary occlusion and reperfusion in the conscious dog.

Authors:  F C White; M Sanders; C M Bloor
Journal:  Am J Cardiol       Date:  1978-08       Impact factor: 2.778

View more
  7 in total

1.  The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.

Authors:  M A Rastegar; F Marchini; G Morazzoni; A Vegh; J G Papp; J R Parratt
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  Modulation of gap junctions by nitric oxide contributes to the anti-arrhythmic effect of sodium nitroprusside?

Authors:  Márton Gönczi; Rita Papp; Mária Kovács; György Seprényi; Agnes Végh
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

3.  Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs.

Authors:  A Vegh; L Szekeres; J R Parratt
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

4.  Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway.

Authors:  A Vegh; L Szekeres; J Parratt
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

5.  Peroxynitrite decreases arrhythmias induced by ischaemia reperfusion in anaesthetized dogs, without involving mitochondrial KATP channels.

Authors:  A Kiss; L Juhász; I Huliák; A Végh
Journal:  Br J Pharmacol       Date:  2008-09-01       Impact factor: 8.739

6.  Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction.

Authors:  E Udvary; J G Papp; A Végh
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

7.  Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors.

Authors:  A Vegh; J G Papp; J Parratt
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.